Heart Disease
Heart Disease Ongoing 2020


To collect data and evaluate the safety of Cardiac Resynchronisation Therapy (CRT) by utilising new techniques and investigational systems for patients in heart failure.

Trial overview

Structural Heart Disease
Eligibility criteria

To be considered for the study you must meet the following criteria:

  • 18 years of age or older
  • Have a diagnosis of heart failure
  • Be clinically indicated for implantation of a CRT device
Study details

Your participation in this study would be for approximately 1-2 months

You will need to go into hospital to have your clinically indicated market-released (approved) CRT device implanted but prior to insertion, a temporary lead will be implanted through the right side of your heart muscle. Images will then be taken to ensure correct lead placement with the use of echocardiography or fluoroscopy. Heart rhythm will also be monitored using an investigational Electrocardiogram (ECG) Belt. After these measurements and images are taken, the temporary lead will be removed, and the permanent market-released CRT device will then be inserted.

Participants will also have a follow-up visit one month after their implant, to assess for medication changes and adverse events.

You will be reimbursed for travel and study expenses.

Sign up to this clinical trial here.



Doncaster East VIC